The National Audit Office says there were 5.3m emergency admissions in the last financial year - a 47% rise in 15 years - and many of these patients stayed in hospital for longer than necessary. Professor of Healthcare Management at Warwick Business School, Eivor Oborn, comments on the report.

The latest GDP figures, a welcome increase of 0.8% for July to September, are the highest quarterly increase in three years and we’ve now had three successive quarters of growth. However, we have to remember that GDP is still about 2.5% beneath its pre-crisis peak. So we’re still producing and consuming less as a nation than we did five years ago. Dean of Warwick Business School, Professor Mark Taylor, gives his thoughts.

Professor Michael Moore, Warwick Business School, gives his thoughts on the UK easing rules for Chinese currency and banks.

Assistant Professor of Finance & Behavioural Science Constantinos Antoniou, of Warwick Business School, is an expert in the behaviour of investors around IPOs. He gives his views on Twitter's latest move.

US pharmaceutical giant Merck's announcement that it is cutting 8,500 jobs is part of a paradigm shift in the industry says Warwick Business School Professor John Lyon. Professor Lyon, who was global vice president of US drug development company Covance, believes Merck’s announcement is part of a realisation that the days of the blockbuster drug are coming to a close.